TTV@Relelvance vs Yoshimitsu | 13–9 | 59.09% |
TTV@Relelvance vs Reina | 12–10 | 54.55% |
TTV@Relelvance vs Paul | 12–4 | 75.00% |
TTV@Relelvance vs Kazuya | 6–8 | 42.86% |
TTV@Relelvance vs Dragunov | 8–6 | 57.14% |
TTV@Relelvance vs Hwoarang | 10–3 | 76.92% |
TTV@Relelvance vs Steve | 9–4 | 69.23% |
TTV@Relelvance vs Heihachi | 8–5 | 61.54% |
TTV@Relelvance vs King | 8–4 | 66.67% |
TTV@Relelvance vs Lee | 11–1 | 91.67% |
TTV@Relelvance vs Jin | 9–2 | 81.82% |
TTV@Relelvance vs Bryan | 8–3 | 72.73% |
TTV@Relelvance vs Asuka | 7–4 | 63.64% |
TTV@Relelvance vs Law | 7–2 | 77.78% |
TTV@Relelvance vs Nina | 6–2 | 75.00% |
TTV@Relelvance vs Victor | 8–0 | 100.00% |
TTV@Relelvance vs Lili | 6–1 | 85.71% |
TTV@Relelvance vs Lars | 6–1 | 85.71% |
TTV@Relelvance vs Jun | 6–1 | 85.71% |
TTV@Relelvance vs Jack-8 | 3–3 | 50.00% |
TTV@Relelvance vs Claudio | 4–2 | 66.67% |
TTV@Relelvance vs Kuma | 3–3 | 50.00% |
TTV@Relelvance vs Azucena | 4–2 | 66.67% |
TTV@Relelvance vs Devil Jin | 2–3 | 40.00% |
TTV@Relelvance vs Leo | 4–1 | 80.00% |
TTV@Relelvance vs Zafina | 4–1 | 80.00% |
TTV@Relelvance vs Xiaoyu | 2–2 | 50.00% |
TTV@Relelvance vs Eddy | 2–2 | 50.00% |
TTV@Relelvance vs Alisa | 2–1 | 66.67% |
TTV@Relelvance vs Shaheen | 2–1 | 66.67% |
TTV@Relelvance vs Lidia | 2–1 | 66.67% |
TTV@Relelvance vs Feng | 2–0 | 100.00% |
TTV@Relelvance vs Leroy | 2–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.